Upjohn plans to produce an anti-baldness drug.
- Share via
The Kalamazoo, Mich.-based drug company said it is investing $23 million in a manufacturing facility for Minoxidil, a drug that it believes could cure male pattern baldness--the type of hair loss that many men experience with advancing age--and patchy baldness--a massive loss of hair all over the body. The drug, which Upjohn first developed as a treatment for high blood pressure, is in the final stages of testing on human volunteers.
Sign up for Essential California
The most important California stories and recommendations in your inbox every morning.
You may occasionally receive promotional content from the Los Angeles Times.
